• FirefoxUpgrade to the new Firefox »
  •  Dow Up0.15% Nasdaq Up0.36%

    Haemonetics Corporation (HAE)

    -NYSE
    37.78 Down 0.39(1.02%) 4:12PM EST
    |After Hours : 37.78 0.00 (0.00%) 4:48PM EST
    Add to Portfolio
    Income StatementGet Income Statement for:
    View: Annual Data | Quarterly DataAll numbers in thousands
    Period EndingMar 29, 2014Mar 30, 2013Mar 31, 2012
    Total Revenue 938,509   891,990   727,844  
    Cost of Revenue470,144  463,859  358,604  
    Gross Profit 468,365   428,131   369,240  
    Operating Expenses
    Research Development54,200  44,394  36,801  
    Selling General and Administrative365,127  323,053  243,681  
    Non Recurring1,711  4,247   -  
    Others -   -   -  
    Total Operating Expenses -   -   -  
    Operating Income or Loss 47,327   56,437   88,758  
    Income from Continuing Operations
    Total Other Income/Expenses Net(10,926)(6,540)740  
    Earnings Before Interest And Taxes36,401  49,897  89,498  
    Interest Expense -   -   -  
    Income Before Tax36,401  49,897  89,498  
    Income Tax Expense1,253  11,097  22,612  
    Minority Interest -   -   -  
    Net Income From Continuing Ops35,148  38,800  66,886  
    Non-recurring Events
    Discontinued Operations -   -   -  
    Extraordinary Items -   -   -  
    Effect Of Accounting Changes -   -   -  
    Other Items -   -   -  
    Net Income 35,148   38,800   66,886  
    Preferred Stock And Other Adjustments -   -   -  
    Net Income Applicable To Common Shares 35,148   38,800   66,886  

    Sign Up for a Free Trial to EDGAR Online Premium!
    Get the critical business and financial information you need for more than 15,000 U.S. public companies.
    Sign Up Now - Learn More

    Currency in USD.